Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „NSCLC“
Suchtreffer
Begriffe & Kennungen
Avastin · 4.8 · In patients with NSCLC excluding predominant squamous histology, all Grade reactions were seen with a frequenc
Eintrag öffnenBraftovi · 4.8 · 17 Ocular events Melanoma and NSCLC In the Combo 450 population, uveitis was reported in 3.5% (13/372) of pati
Eintrag öffnenBraftovi · 4.8 · 18 Pancreatitis Melanoma and NSCLC In the Combo 450 ISP, pancreatic enzyme elevation, mostly asymptomatic, was
Eintrag öffnenBraftovi · 4.8 · Anaemia Melanoma and NSCLC In the Combo 450 ISP, anaemia was reported in 23.1% (86/372) of patients; 7.0% (26/
Eintrag öffnenBraftovi · 4.8 · Cutaneous malignancies Cutaneous squamous cell carcinoma Melanoma and NSCLC In the Combo 450 ISP, cuSCC includ
Eintrag öffnenBraftovi · 4.8 · Dermatitis acneiform Melanoma and NSCLC Dermatitis acneiform was reported when encorafenib is used in combinat
Eintrag öffnenBraftovi · 4.8 · Dermatologic reactions Rash Melanoma and NSCLC In the Combo 450 ISP, rash occurred in 20.4% (76/372) of patien
Eintrag öffnenBraftovi · 4.8 · Elderly Melanoma and NSCLC In patients treated with Combo 450 ISP (n = 372), 230 patients (61.8%) were <65 yea
Eintrag öffnenBraftovi · 4.8 · Facial paresis Melanoma and NSCLC In the Combo 450 ISP, facial paresis occurred in 0.8% (3/372) of patients in
Eintrag öffnenBraftovi · 4.8 · Fatigue Melanoma and NSCLC In the Combo 450 ISP, fatigue occurred in 48.1% (179/372) of patients including Gra
Eintrag öffnenBraftovi · 4.8 · Gastrointestinal disorders Melanoma and NSCLC In the Combo 450 ISP, diarrhoea was observed in 41.7% (155/372)
Eintrag öffnenBraftovi · 4.8 · Haemorrhage Melanoma and NSCLC Haemorrhagic events were observed in 16.7% (62/372) of patients in the Combo 45
Eintrag öffnenBraftovi · 4.8 · Headache Melanoma and NSCLC In the Combo 450 ISP, headache occurred in 18.8% (70/372) of patients, including G
Eintrag öffnenBraftovi · 4.8 · Liver laboratory abnormality Melanoma and NSCLC The incidences of liver laboratory abnormalities reported in t
Eintrag öffnenBraftovi · 4.8 · Palmar-plantar erythrodysaesthesia syndrome (PPES) Melanoma and NSCLC PPES was reported in 5.1% (19/372) of pa
Eintrag öffnenBraftovi · 4.8 · Photosensitivity Melanoma and NSCLC In the Combo 450 ISP, photosensitivity was observed in 4.3% (16/372) of pa
Eintrag öffnenBraftovi · 4.8 · Renal dysfunction Melanoma and NSCLC In the Combo 450 ISP, mild, mostly Grade 1, asymptomatic blood creatinine
Eintrag öffnenCyramza · 4.3 · For patients with NSCLC, ramucirumab is contraindicated where there is tumour cavitation or tumour involvement
Eintrag öffnenGiotrif · 4.8 · Tabulated list of adverse reactions Table 2 summarises the frequencies of ADRs from all NSCLC trials and from
Eintrag öffnenImfinzi · 4.8 · In first line metastatic NSCLC patients in the POSEIDON study, some differences in safety were reported betwee
Eintrag öffnen